These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 11213897)
21. Peroxisome proliferator-activated receptor-gamma in vascular biology. Li J; Wang N Cardiovasc Hematol Disord Drug Targets; 2007 Jun; 7(2):109-17. PubMed ID: 17584045 [TBL] [Abstract][Full Text] [Related]
22. [A role of the PPAR gamma activation in insulin resistance]. Yoshimasa Y Nihon Rinsho; 2001 Nov; 59(11):2173-8. PubMed ID: 11712403 [TBL] [Abstract][Full Text] [Related]
23. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Chawla A; Barak Y; Nagy L; Liao D; Tontonoz P; Evans RM Nat Med; 2001 Jan; 7(1):48-52. PubMed ID: 11135615 [TBL] [Abstract][Full Text] [Related]
24. A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice. Fukui Y; Masui S; Osada S; Umesono K; Motojima K Diabetes; 2000 May; 49(5):759-67. PubMed ID: 10905484 [TBL] [Abstract][Full Text] [Related]
25. Thiazolidinediones--tools for the research of metabolic syndrome X. Komers R; Vrána A Physiol Res; 1998; 47(4):215-25. PubMed ID: 9803467 [TBL] [Abstract][Full Text] [Related]
26. Diabetes mellitus and macrovascular disease: mechanisms and mediators. Boyle PJ Am J Med; 2007 Sep; 120(9 Suppl 2):S12-7. PubMed ID: 17826041 [TBL] [Abstract][Full Text] [Related]
27. Activation of peroxisome proliferator-activated receptor gamma inhibits osteoprotegerin gene expression in human aortic smooth muscle cells. Fu M; Zhang J; Lin Yg Yg; Zhu X; Willson TM; Chen YE Biochem Biophys Res Commun; 2002 Jun; 294(3):597-601. PubMed ID: 12056809 [TBL] [Abstract][Full Text] [Related]
28. Regulation of macrophage gene expression by the peroxisome proliferator-activated receptor-gamma. Ricote M; Welch JS; Glass CK Horm Res; 2000; 54(5-6):275-80. PubMed ID: 11595817 [TBL] [Abstract][Full Text] [Related]
29. Thiazolidinedione regulation of smooth muscle cell proliferation. Bruemmer D; Law RE Am J Med; 2003 Dec; 115 Suppl 8A():87S-92S. PubMed ID: 14678872 [TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cells. Hellemans K; Michalik L; Dittie A; Knorr A; Rombouts K; De Jong J; Heirman C; Quartier E; Schuit F; Wahli W; Geerts A Gastroenterology; 2003 Jan; 124(1):184-201. PubMed ID: 12512042 [TBL] [Abstract][Full Text] [Related]
31. [Peroxisome proliferator activated nuclear receptors: possible role in the development of atherosclerosis]. Evdokimova MA; Zateĭshchikov DA; Sidorenko BA Kardiologiia; 2003; 43(11):41-8. PubMed ID: 14671562 [TBL] [Abstract][Full Text] [Related]
32. Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insulin-sensitive tissues. Way JM; Harrington WW; Brown KK; Gottschalk WK; Sundseth SS; Mansfield TA; Ramachandran RK; Willson TM; Kliewer SA Endocrinology; 2001 Mar; 142(3):1269-77. PubMed ID: 11181544 [TBL] [Abstract][Full Text] [Related]
33. [Peroxisome proliferator-activated receptors (PPAR) in pathophysiology of the circulatory system and prospective use of agonists of these receptors in therapy]. Bełtowski J; Wójcicka G; Jamroz A Postepy Hig Med Dosw; 2003; 57(2):199-217. PubMed ID: 12866356 [TBL] [Abstract][Full Text] [Related]
34. Peroxisome proliferator-activated receptor gamma and metabolic disease. Willson TM; Lambert MH; Kliewer SA Annu Rev Biochem; 2001; 70():341-67. PubMed ID: 11395411 [TBL] [Abstract][Full Text] [Related]
35. Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature. Guan Y; Zhang Y; Schneider A; Davis L; Breyer RM; Breyer MD Am J Physiol Renal Physiol; 2001 Dec; 281(6):F1036-46. PubMed ID: 11704554 [TBL] [Abstract][Full Text] [Related]
36. Cyclic phosphatidic acid inhibits the secretion of vascular endothelial growth factor from diabetic human coronary artery endothelial cells through peroxisome proliferator-activated receptor gamma. Tsukahara T; Tsukahara R; Haniu H; Matsuda Y; Murakami-Murofushi K Mol Cell Endocrinol; 2015 Sep; 412():320-9. PubMed ID: 26007326 [TBL] [Abstract][Full Text] [Related]
37. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization. Murata T; He S; Hangai M; Ishibashi T; Xi XP; Kim S; Hsueh WA; Ryan SJ; Law RE; Hinton DR Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2309-17. PubMed ID: 10892878 [TBL] [Abstract][Full Text] [Related]
38. Effects of PPAR gamma agonists on cardiovascular function in obese, non-diabetic patients. Panunti B; Fonseca V Vascul Pharmacol; 2006 Jul; 45(1):29-35. PubMed ID: 16777491 [TBL] [Abstract][Full Text] [Related]
39. Early stimulation and late inhibition of peroxisome proliferator-activated receptor gamma (PPAR gamma) gene expression by transforming growth factor beta in human aortic smooth muscle cells: role of early growth-response factor-1 (Egr-1), activator protein 1 (AP1) and Smads. Fu M; Zhang J; Lin Y; Zhu X; Zhao L; Ahmad M; Ehrengruber MU; Chen YE Biochem J; 2003 Mar; 370(Pt 3):1019-25. PubMed ID: 12457461 [TBL] [Abstract][Full Text] [Related]